choroidal lesions with blurred vision in the right eye due to macular oedema. This gradually improved, though visual acuity remained somewhat reduced due to chronic posterior uveitis. In August 1974 chest radiographs showed peripheral lung mottling and her maintenance dose of corticosteroid was increased to 10 mg daily.
Discussion
Heerfordt's syndrome is an unusual manifestation of sarcoidosis consisting of parotitis with chronic or subacute uveitis and often complicated by cranial nerve pareses, usually of the facial nerve. Originally described in 1909,1 it was not recognised as a manifestation of sarcoidosis until 1937. The complete picture is rare. Scadding2 had no cases of the complete syndrome in his series, and Greenberg et al,3 reviewing 388 cases of sarcoidosis, reported only 8 with uveoparotitis and only one with a facial palsy. Familial association in sarcoidosis is well recognised.4 In 13 instances of sarcoidosis affecting identical twins the manifestations of the disease in each twin pair tended to be similar.5 This seems to be true of less closely related subjects. Interestingly, both our cases presented almost simultaneously with a most uncommon form of sarcoidosis and followed very similar courses.
'Heerfordt, C F, Albrecht v Graefes Archivfur Ophthalomolgie, 1909, 70, 254. 2 Scadding, J G, in Sarcoidosis. London, Eyre and Spottiswoode, 1967. 3 Greenberg, G, et al, British Medical_Journal, 1964, 2, 861. Of the 30 patients examined four had taken practolol for 6 months, the remaining 26 had taken it for at least a year. Ten showed signs of ocular toxicity and 20 showed no signs. Eight of the 10 toxic patients had been off practolol for periods varying from 1 to 12 weeks (average 6 4 weeks). We assayed the lysozyme concentration in the tear fluid of both eyes of all the patients by our quantitative method with calibrated standards,3 the measurements being in units of activity/Ll.
All the 10 toxic patients had tear lysozyme concentrations below normal in one or both eyes (see table) . In one patient (case 2) lysozyme was absent. In 3 of the 10 patients (cases 1, 3, 7) the concentration in one eye was about three times that of the other, and in one patient (case 4) it was 9 times. These differences are outside normal limits of variation between the two eyes.3
Of the 20 patients with no signs of toxicity 15 had normal tear lysozyme concentrations (see table) . One (case 19) had low concentrations in both eyes. Three (cases 11, 14, 26) had low concentrations in one eye, but the differences in concentrations between the two eyes were within normal limits. In one patient (case 17) the initial concentrations were 201 U4d right and 57 U/pi left. A month later they were 16 U/,ul and 25 U/,ul respectively-a striking fall. A month after that (in January) the patient developed signs of toxicity and practolol was stopped. In May the concentrations had risen to 40 U/lI and 45 U/lI, and in July to 120 U/lI and 60 U/IAL.
We also examined two patients with sclerosing peritonitis due to practolol but with no signs of ocular toxicity. Both had abnormally low levels of tear lysozyme (45 U/p1 and 55 U/II, and 30 U/lA and 36 U/pA1 respectively). One, in whom lysozyme levels fell further, later developed signs of ocular toxicity. In acute viral hepatitis (AVH) several neurological complications have been described. The central' and the peripheral2 nervous systems may be affected, but the Guillain-Barre syndrome (GBS), characterised by progressive symmetrical pareses, sensory loss, and a raised spinal fluid protein level with normal cell count, is extremely rare in the course of AVH.3 We report here on a patient who developed hepatitis B and GBS and in whom we were able to define accurately the relation between the onset of hepatitis B and the onset of GBS.
Case report
The patient was a 21-year-old nurse seronegative for hepatitis B surface antigen (HBsAg) in a haemodialysis unit with HBsAg (subtype adw)-positive patients. The clinical course of her disease is summarised in the figure. On 1 June (day 1) her serum, which was being checked routinely every two weeks, contained HBsAg, subtype adw, and the transaminases had risen slightly, but were still within normal limits. Nausea, vomiting, and upper abdominal discomfort then developed and on day 11 she was admitted to hospital. By then she had no complaints. There was no history of arthralgia, exanthema, skin eruptions, or fever, nor of intolerance to fat or tobacco. She did not use any medication. Her father had had a polyneuropathy complicating diphtheria in 1930. Physical examination showed jaundice and a tender, 1-cm palpable, liver. The spleen was not palpable and there were no spider nevi or liver palms. On day 20 neurological symptoms developed (see figure) . Spinal fluid protein was raised (1-8 g/l); cell count, glucose, and chloride were normal; and HBsAg was not demonstrable. Respiratory musculature became affected: vital capacity measured 1200, 950, and 600 ml on days 22, 23, and 24 respectively. Tracheotomy was performed on day 24 and assisted ventilation started. From day 28 the patient improved neurologically and on day 48 assisted ventilation was discontinued. By then neurological functions were normal, with the exception of a right-sided facial paresis, which only subsided after five months. On day 28 HBsAg conversion, accompanied by proteinuria, became fully apparent. At day 63 she had become negative for SMA and positive for serum anti-HBs, while bilirubin and transaminases had become normal. A repeat biospy showed slight prominence of Kupffer cells and small periportal connective tissue strands. After mobilisation at day 67 the liver function remained normal and recovery was uneventful.
Attempts to show laboratory evidence of several viral infections associated with GBs all failed. Apart from SMA no autoantibodies (including antimyelin antibody") were present.
Comment
Although GBS may be elicited by viral infections of different origin, it is rare in AVH and we are not aware of documented cases of GBS after acute HBsAg-positive hepatitis. Our patient developed GBS 20 days after the first, preclinical, manifestation of hepatitis B.
The condition was completely reversible.
The Scandinavica, 1950, 137, 322. 2 Steme, J, Presse Midicale, 1953, 61, 663. 3 Plough, I C, and Ayerle, R S, New Englandyournal of Medicine, 1953, 249, 61. 4 Edgington, T, and Dalessio, D J,Journal of Immunology, 1970 , 105, 248. 5 Peters, D K, et al, Lancet, 1973 , 1, 1183 Divisions ofInfectious Diseases and Hepatology, University Hospital, Groningen, Netherlands P NIERMEIJER, MD, consultant hepatologist C H GIPS, mD, consultant hepatologist Pasteurella multocida septicaemia associated with chronic liver disease
In the case of the patient with chronic liver disease and terminal Pasteurella multocida septicaemia reported here the organism was possibly acquired from a dog, though there was no history of an antecedent bite.
Case report
The patient, an 18-year-old man, had had recurrent bronchitis in infancy and at 22 months had been admitted to hospital with bronchopneumonia and hepatomegaly. A liver biopsy had shown biliary fibrosis and bile ductular proliferation with no evidence of cirrhosis. The result of a sweat test and duodenal trypsin, serum copper, and caeruloplasmin levels were normal. In February 1974 he was referred to the Professorial Medical Unit, Southampton. The liver and spleen were grossly enlarged and the results of liver function tests were: total bilirubin 102 iLmol/l (6 mg/100 ml), alkaline phosphatase 41 KAU/100 ml, total plasma protein 56 g/l, plasma albumin 30 g/l. Tests for autoimmunity were negative, HB antigen and alphafetoprotein were not detected, and the alpha-l-antitrypsin level was normaL A clinical diagnosis of biliary cirrhosis secondary to partial biliary atresia was made.
In November 1974 he was admitted with increasing jaundice, abdominal pain, and vomiting. He was deeply jaundiced (total bilirubin more than 342 zmol/l (20 mg/100 ml)), feverish, and hypotensive. Blood cultures grew P. multocida sensitive to ampicillin. He was treated with ampicillin and a standard regimen for hepatic failure. Serum agglutination tests for Yersima pseudotuberculosis and Y. enterocolitica were negative. His temperature fell to normal but his general condition deteriorated and he died two weeks after admission.
At necropsy the liver was found to be small and finely nodular. The common bile duct was patent and the intrahepatic biliary system consisted partly of a cavity, 8 cm by 4 cm, filled with a mass of fused pigment stones and inspissated bile. On sectioning the liver there were two discrete nodules, which were shown histologically to be hepatocellular carcinomas; the remainder of the liver showed secondary biliary cirrhosis (see fig). A mass of A,.
Area of secondary biliary cirrhosis and cholestasis. (Haematoxylin and eosin x 60.)
